KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Astrana Health (ASTH) Receivables - Net (2016 - 2025)

Astrana Health's Receivables - Net history spans 15 years, with the latest figure at $381.2 million for Q3 2025.

  • For Q3 2025, Receivables - Net rose 401.53% year-over-year to $381.2 million; the TTM value through Sep 2025 reached $381.2 million, up 401.53%, while the annual FY2024 figure was $276.0 million, 259.46% up from the prior year.
  • Receivables - Net for Q3 2025 was $381.2 million at Astrana Health, up from $348.7 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $381.2 million in Q3 2025 and bottomed at $1.0 million in Q1 2022.
  • The 5-year median for Receivables - Net is $47.2 million (2024), against an average of $89.1 million.
  • The largest annual shift saw Receivables - Net crashed 93.88% in 2022 before it soared 7447.67% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $10.6 million in 2021, then surged by 37.27% to $14.6 million in 2022, then soared by 427.26% to $76.8 million in 2023, then soared by 259.46% to $276.0 million in 2024, then soared by 38.13% to $381.2 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Receivables - Net are $381.2 million (Q3 2025), $348.7 million (Q2 2025), and $54.9 million (Q1 2025).